ESMO Breast 2020 View overview page

7:15
Characterizing the immune microenvironment before and following anti-HER2 neoadjuvant therapy
Gaia Griguolo • 12 May 2020
3:58
Decision-making process for patients involved in clinical trials
Gabriella Pravettoni • 11 May 2020
4:26
Radiomics in the prediction of immunophenotypes in male breast cancer
Venkata Pradeep Babu • 6 May 2020
3:05
Exploring the use of olaparib in advanced breast cancer
Gaia Griguolo • 21 May 2020
4:29
Empowering communication in emergency care as a result of COVID-19
Gabriella Pravettoni • 20 May 2020
4:18
Value of radiomics and AI in cancer treatment
Venkata Pradeep Babu • 12 May 2020
6:19
The future of breast cancer treatment
Gaia Griguolo • 21 May 2020
2:29
COVID-19 related stress and burnout in hospital staff
Gabriella Pravettoni • 20 May 2020
4:45
Advances and considerations in the treatment and management of HR+, HER2-, advanced breast cancer
Hans-Christian Kolberg • 13 May 2020
2:42
LILAC: comparing cardiac safety of ABP 980 with trastuzumab
Hans-Christian Kolberg • 13 May 2020
3:26
Chemo-immunotherapy for TNBC
Evandro de Azambuja • 20 May 2020
2:29
Using genomic techniques to guide personalized medicine in breast cancer
Serafin Morales • 19 May 2020
2:06
PHranceSCa: evaluating patient satisfaction with subcutaneous pertuzumab and trastuzumab treatment
Evandro de Azambuja • 12 May 2020
5:04
Latest news in breast cancer surgery
Walter Weber • 21 May 2020
1:01
Chemo-immunotherapy for TNBC
Serafin Morales • 12 May 2020
3:36
The impact of coronavirus on patient-doctor interactions in Portugal
Pedro Gouveia • 12 May 2020
The content of VJOncology is intended for healthcare professionals